Search

everythinglearnresearchcommunity

for

Search:↓

ERG increases SOX9, promoting prostate cancer growth and invasion.

Colorectal cancer development involves both genetic changes and epigenetic alterations like DNA methylation and microRNA changes.

Prostate cancer was a major health issue in 2009, especially for Black men, and targeting the 5alpha-reductase enzyme could help in its prevention and treatment.

5α-reductase inhibitors may prevent prostate cancer but could also raise the risk of more severe cancers.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

Selenium and vitamin E supplements have mixed effects on prostate cancer risk and may not be beneficial for everyone.

The Hedgehog signaling pathway is important for skin and hair growth and can lead to cancer if it doesn't work right.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

The fish oil-based gel with imiquimod improves skin cancer treatment and reduces inflammation.

Steroid sex hormones activate matriptase in prostate cancer cells but not in breast cancer cells.

Vitamin D receptor may help protect against UV-induced skin cancer.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

Finasteride might lower the risk of low-grade prostate cancer but not high-grade cancer, while alpha-blockers might reduce high-grade cancer risk.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Men who experienced baldness at age 20 may have double the risk of getting prostate cancer.

A cancer patient died from a severe skin reaction after taking the drug cetuximab.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

A specific gene variant is linked to a higher risk of hair loss from chemotherapy in breast cancer patients.

Male cancer patients have a higher risk of severe illness and death from COVID-19 than female patients.

The study found no link between baldness patterns and androgen levels in men with benign prostate enlargement or prostate cancer.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Baldness at age 40 is not linked to a higher risk of aggressive prostate cancer.

Suppressing certain hormones might help prevent prostate cancer.

Chemotherapy causes hair loss starting soon after treatment begins and recovers about 3 months after ending, while tamoxifen does not significantly affect hair growth.

A woman with cervical cancer had rare scalp metastasis causing a unique type of hair loss.

The document suggests a possible link between FAM111B gene mutations and increased cancer risk, particularly pancreatic cancer.